OOIR: Observatory of International Research

Papers

(The median citation count of Critical Reviews in Clinical Laboratory Sciences is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
COVID-19: from an acute to chronic disease? Potential long-term health consequences	237
Current concepts and advances in biomarkers of acute kidney injury	102
Vitamin B₁₂status in health and disease: a critical review. Diagnosis of deficiency and insufficiency – clinical and laboratory pitfalls	75
The COVID-19 pandemic: viral variants and vaccine efficacy	73
Vitamin D: sources, physiological role, biokinetics, deficiency, therapeutic use, toxicity, and overview of analytical methods for detection of vitamin D and its metabolites	73
Potential value and impact of data mining and machine learning in clinical diagnostics	62
Effects of age, sex, serostatus, and underlying comorbidities on humoral response post-SARS-CoV-2 Pfizer-BioNTech mRNA vaccination: a systematic review	61
Molecular diagnostic assays for COVID-19: an overview	52
Breathing new life into clinical testing and diagnostics: perspectives on volatile biomarkers from breath	29
The molecular structure and biological functions of RNA methylation, with special emphasis on the roles of RNA methylation in autoimmune diseases	28
Nucleic acid-based electrochemical biosensors for rapid clinical diagnosis: advances, challenges, and opportunities	27
Molecular tissue profiling by MALDI imaging: recent progress and applications in cancer research	26
Oligoclonal bands: clinical utility and interpretation cues	21
Procalcitonin for individualizing antibiotic treatment: an update with a focus on COVID-19	21
The potential impact of salivary peptides in periodontitis	20
Lean and Six Sigma as continuous quality improvement frameworks in the clinical diagnostic laboratory	19
T helper cells in depression: central role of Th17 cells	19
Choice of SARS-CoV-2 diagnostic test: challenges and key considerations for the future	19
Development of circulating microRNA-based biomarkers for medical decision-making: a friendly reminder of what should NOT be done	19
Personalized reference intervals: from theory to practice	17
Quantifying RNA modifications by mass spectrometry: a novel source of biomarkers in oncology	17
CRISPR-based biosensing systems: a way to rapidly diagnose COVID-19	17
DropWise: current role and future perspectives of dried blood spots (DBS), blood microsampling, and their analysis in sports drug testing	16
Systematic review and meta-analysis of C-reactive protein as a biomarker in breast cancer	16
Immunologic evaluation and genetic defects of apoptosis in patients with autoimmune lymphoproliferative syndrome (ALPS)	15

Clinical utility of procalcitonin and its association with pathogenic microorganisms	14
Progress in understanding COVID-19: insights from the omics approach	13
Presentation and formatting of laboratory results: a narrative review on behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group “postanalytical phase” (WG	12
Impact of body mass index on growth hormone stimulation tests in children and adolescents: a systematic review and meta-analysis	12
Free thyroxine measurement in clinical practice: how to optimize indications, analytical procedures, and interpretation criteria while waiting for global standardization	11
Disruptive innovations in the clinical laboratory: catching the wave of precision diagnostics	11
Emerging applications of machine learning in genomic medicine and healthcare	11
Evaluation of pathophysiological relationships between renin-angiotensin and ACE-ACE2 systems in cardiovascular disorders: from theory to routine clinical practice in patients with heart failure	11
Clot activators and anticoagulant additives for blood collection. A critical review on behalf of COLABIOCLI WG-PRE-LATAM	11
Physiological and metabolic adaptations in pregnancy: importance of trimester-specific reference intervals to investigate maternal health and complications	11
Current understanding and controversies on the clinical implications of fibroblast growth factor 21	11
Metabolomics of asthma, COPD, and asthma-COPD overlap: an overview	11
Evaluating thyroid function in pregnant women	11
Screening and diagnosis of inherited platelet disorders	10
Oxidized LDL-regulated microRNAs for evaluating vascular endothelial function: molecular mechanisms and potential biomarker roles in atherosclerosis	10
Novel biomarkers in Alzheimer’s disease using high resolution proteomics and metabolomics: miRNAS, proteins and metabolites	9
New biomarkers in acute kidney injury	9
Clinical features and diagnostic tools in idiopathic inflammatory myopathies	8
Cardiovascular benefit of SGLT2 inhibitors	8
Hereditary breast and ovarian cancer: from genes to molecular targeted therapies	7
Von Willebrand factor and disease: a review for laboratory professionals	7
Reference intervals: past, present, and future	7
Beyond the amyloid hypothesis: how current research implicates autoimmunity in Alzheimer’s disease pathogenesis	7
Technical quality assurance and quality control for medical laboratories: a review and proposal of a new concept to obtain integrated and validated QA/QC plans	7
Current and emerging technologies for the timely screening and diagnosis of neonatal jaundice	7
Biomarkers of disease in human nails: a comprehensive review	7
Overutilization in laboratory medicine: tackling the problem with quality improvement science	7
Current status and challenges in establishing reference intervals based on real-world data	6
Pathogenicity and virulence of human T lymphotropic virus type-1 (HTLV-1) in oncogenesis: adult T-cell leukemia/lymphoma (ATLL)	6
Pre-analytical conditions and implementation of quality control steps in liquid biopsy analysis	6
Complement testing in the clinical laboratory	5
Using a systematic approach to strategic innovation in laboratory medicine to bring about change	5
Analytical performance specifications and quality assurance of point-of-care testing in primary healthcare	5
Design, optimization, and application of multiplex rRT-PCR in the detection of respiratory viruses	5
The genomic and biological complexity of mixed phenotype acute leukemia	5
Developing an SI-traceable Lp(a) reference measurement system: a pilgrimage to selective and accurate apo(a) quantification	5
Cytogenetic and molecular genetic methods for chromosomal translocations detection with reference to the KMT2A/MLL gene	5
Immunohistochemistry features and molecular pathology of appendiceal neoplasms	5
Advances in minimal residual disease monitoring in multiple myeloma	5
Prostate cancer biomarkers: a practical review based on different clinical scenarios	4
The therapeutic relevance of the Kallikrein-Kinin axis in SARS-cov-2-induced vascular pathology	4
It’s in the blood: a review of the hematological system in SARS-CoV-2-associated COVID-19	4
Erroneous potassium results: preanalytical causes, detection, and corrective actions	4
General features, pathogenesis, and laboratory diagnostics of autoimmune encephalitis	4
Newborn screening of mucopolysaccharidosis type I	4
Molecular effects of ozone on amino acids and proteins, especially human hemoglobin and albumin, and the need to personalize ozone concentration in major ozone autohemotherapy	4
Circulating tumor DNA (ctDNA): can it be used as a pan-cancer early detection test?	4
Laboratory testing for mitochondrial diseases: biomarkers for diagnosis and follow-up	4
Revisiting approaches to and considerations for urinalysis and urine culture reflexive testing	4